OS Therapies, Inc. is seeking regulatory approval from the European Medicines Agency for a new cancer treatment.
2 reports, 1 independent
Updated Sep 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OS Therapies, Inc. is seeking regulatory approval from the European Medicines Agency for a new cancer treatment.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
Related events
- Both the FDA and the European Medicines Agency govern drug approval processes.
- The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.
- AbbVie submitted an application for risankizumab approval to the European Medicines Agency.
- A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.
- The FDA and European Medicines Agency discussed sharing the global regulatory leadership mantle.